• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

ApolloMed & BASS Medical Partner to Transform Value-Based Care in Northern California

by Fred Pennic 02/01/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
ApolloMed & BASS Medical Partner to Transform Value-Based Care in Northern California

What You Should Know:

– Apollo Medical Holdings (NASDAQ: AMEH), a provider-centric healthcare company, and BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area, announced today a strategic partnership aimed at revolutionizing value-based care in Northern California.

– The strategic alliance between ApolloMed and BASS Medical Group promises to significantly impact the healthcare landscape in California.

Bolstering Value-Based Care Infrastructure

The partnership focuses on strengthening BASS Medical Group’s value-based care capabilities and operational infrastructure. ApolloMed will deploy its industry-leading platform and solutions across BASS Medical Group’s 400+ providers and nearly 200 locations throughout Northern California. This will enable them to effectively participate in total cost of care arrangements and build integrated care models that seamlessly connect primary and multi-specialty care.

Expanding Access and Improving Quality

Through this collaboration, both organizations aim to deliver high-quality care through value-based arrangements to patients with diverse insurance coverage, including Medicare, Medicaid, ACA Marketplace, and commercial plans. BASS Medical Group will transition all existing value-based agreements to this partnership, and ApolloMed will become their exclusive partner for all future value-based arrangements.

Expanding Footprint and Investment

ApolloMed’s commitment to BASS Medical Group’s success extends beyond technology and infrastructure. ApolloMed has provided a $20M senior secured promissory note to support BASS Medical Group’s continued growth and investment in high-quality, accessible primary and multi-specialty care across California. This investment will enable them to enter new markets in Santa Clara and Alameda Counties, as well as expand their presence in existing locations.

“We are thrilled to partner with BASS Medical Group, a like-minded organization that shares our commitment to empowering providers, prioritizing the patient-provider relationship, and delivering high-quality, compassionate care,” stated Brandon Sim, President and CEO of ApolloMed. “Together, we will focus on aligning primary and specialty care in value-based models to improve patient care across Northern California and beyond.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Value-Based Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |